Pegylated interferon alpha - 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial (Q39005456)
Jump to navigation
Jump to search
scientific article published on 5 January 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pegylated interferon alpha - 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial |
scientific article published on 5 January 2017 |
Statements
1 reference
Pegylated interferon alpha - 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial (English)
1 reference
K Gowin
1 reference
T Jain
1 reference
H Kosiorek
1 reference
R Tibes
1 reference
J Camoriano
1 reference
J Palmer
1 reference
R Mesa
1 reference
5 January 2017
1 reference
1 reference
Identifiers
1 reference